Management of comorbid bipolar disorder and substance use disorders.
- Authors
- Salloum, Ihsan M; Brown, Edson Sherwood
- Year
- 2017
- Journal
- The American journal of drug and alcohol abuse
- PMID
- 28301219
- DOI
- 10.1080/00952990.2017.1292279
BACKGROUND: The comorbidity of substance use disorders (SUDs) in bipolar disorder is among the highest in psychiatric disorders. Evidence-based controlled psychosocial or pharmacological interventions trials, which may guide treatment decisions, have not been systematically reviewed. OBJECTIVE: To present a narrative review of the public health and clinical significance of this condition, including diagnostic and treatment implications, and to evaluate controlled trials conducted to date. METHODS: Controlled trials reports in the English language were identified from multiple electronic databases and hand-searching bibliographies. We searched for treatment studies of bipolar disorder and comorbid SUDs (alcohol, cocaine, stimulants, opioid, tobacco, cannabis). Search period included all reports through September of 2016. We selected only randomized psychosocial studies or double-blind, placebo-controlled pharmacotherapy trials. We also reviewed reports of the public health and clinical significance and principle of managements of this condition. RESULTS: We identified 16 treatment studies: 3 psychotherapy, and 13 pharmacotherapy trials. The following medications were evaluated: lithium carbonate, valproate, lamotrigine, topiramate, naltrexone, acamprosate, disulfiram, quetiapine, and citicoline. SUDs have substantial impact on the recognition and management of bipolar disorder. Integrated psychosocial interventions are helpful in decreasing substance abuse. Valproate and naltrexone may decrease alcohol use and citicoline may decrease cocaine use and enhance cognition. CONCLUSIONS: There is a very limited number of pharmacotherapy and an even smaller number of psychosocial interventions. Our review highlights the need for more research in this area and for larger, multisite studies with generalizable samples to provide more definite guidance for clinical practice.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | 2023 | 37626487 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Clinical practice guidelines for the management of bipolar disorder: 2025 update. | Menon V et al. | — | 2026 | → |
| Correlates of alcohol use and alcohol use disorder among youth with bipolar disorder. | Sultan AA et al. | — | 2026 | → |
| Brain structural correlates of prior alcohol use disorder and their relation to cognitive impairment in individuals with mood disorders. | Miskowiak KW et al. | — | 2025 | → |
| Comprehensive Review on Association of Bipolar Disorder and Substance Abuse: Dual Diagnosis and Treatment Approaches. | Bonner-Reid FT et al. | — | 2025 | → |
| Discontinuity of psychiatric care among patients with bipolar disorder in the Netherlands. | van der Lee AP et al. | — | 2025 | → |
| Heterogeneity analysis provides evidence for a genetically homogeneous subtype of bipolar-disorder. | McGrouther CC et al. | — | 2025 | → |
| Maternal cognitive functioning and psychopathology predict quality of parent-child relationship in the context of substance use disorder: A 15-month longitudinal study. | Porreca A et al. | — | 2025 | → |
| Navigating the challenges of substance use and psychopathology in depression, bipolar disorder, and schizophrenia. | Chiappini S et al. | — | 2025 | → |
| Lifetime prevalence of psychiatric comorbidities in patients with bipolar disorder: A systematic review and meta-analysis. | Léda-Rêgo G et al. | — | 2024 | → |
| Pharmacist-Driven Alcohol Use Disorder Screening May Increase Inpatient Utilization of Extended-Release Naltrexone: A Single Center Pilot Study. | Snyder S et al. | — | 2024 | → |
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | Preuss UW et al. | — | 2023 | → |
| Assessing the risk of COVID-19 reinfection and severe outcomes among individuals with substance use disorders: a retrospective study using real-world electronic health records. | Tuan WJ et al. | — | 2023 | → |
| Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management. | Sesso G et al. | — | 2023 | → |
| Crossed clinical features between eating disorders and types of bipolar disorder: Results from the FondaMental Advanced Centers of Expertise - Bipolar Disorder cohort. | Flaudias V et al. | — | 2023 | → |
| Current Perspectives on Selective Dopamine D<sub>3</sub> Receptor Antagonists/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders. | Newman AH et al. | — | 2023 | → |
| Extracellular Vesicles in Mental Disorders: A State-of-art Review. | Kong L et al. | — | 2023 | → |
| Gender and addiction and other mental disorders comorbidity: sociodemographic, clinical, and treatment differences. | Fernández SD et al. | — | 2023 | → |
| Multimorbidity and Correlates of Comorbid Depression and Generalized Anxiety Disorder in a Nationally Representative US Sample. | Jegede O et al. | — | 2023 | → |
| Relapse among MHCUs after a Short-Term Admission in an Acute Psychiatric Unit: Primary Caregivers' Perspective. | Raluthaga N et al. | — | 2023 | → |
| Triple Diagnosis of Attention-Deficit/Hyperactivity Disorder with Coexisting Bipolar and Alcohol Use Disorders: Clinical Aspects and Pharmacological Treatments. | Weiss F et al. | — | 2023 | → |
| Blood-brain barrier dysfunction in bipolar disorder: Molecular mechanisms and clinical implications. | Zhao NO et al. | — | 2022 | → |
| Citicoline: pharmacological and clinical review, 2022 update. | Secades JJ et al. | — | 2022 | → |
| Comorbidity of adult ADHD and substance use disorder in a sample of inpatients bipolar disorder in Iran. | Badrfam R et al. | — | 2022 | → |
| Eosinophils to Lymphocytes Ratio (ELR) as a Potential Inflammatory Biomarker in Patients with Dual Diagnosis of Bipolar and Alcohol Use Disorders: A Retrospective Cohort Study. | Dirani E et al. | — | 2022 | → |
| Establishing a System of Care for Severe and Refractory Dual Disorder in the State of Hawai'i. | Busch G et al. | — | 2022 | → |
| Impaired risk avoidance in bipolar disorder and substance use disorders. | Gold AK et al. | — | 2022 | → |
| Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review. | Fischler PV et al. | — | 2022 | → |
| Outcomes of Hospitalized Acute Alcoholic Hepatitis (AH) in Patients With Bipolar 1 Disorder (B1D). | Kaye AJ et al. | — | 2022 | → |
| Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study. | Icick R et al. | — | 2022 | → |
| Rates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative U.S sample. | Jegede O et al. | — | 2022 | → |
| Schema Therapy for Patients with Bipolar Disorder: Theoretical Framework and Application. | Ociskova M et al. | — | 2022 | → |
| The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. | McIntyre RS et al. | — | 2022 | → |
| Advances in the psychopharmacotherapy of bipolar disorder type I. | Sleem A et al. | — | 2021 | → |
| A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder. | Sherwood Brown E et al. | — | 2021 | → |
| Bipolar Disorder and Comorbid Use of Illicit Substances. | Preuss UW et al. | — | 2021 | → |
| Comorbid Bipolar and Alcohol Use Disorder-A Therapeutic Challenge. | Grunze H et al. | — | 2021 | → |
| Genetic contributions to bipolar disorder: current status and future directions. | O'Connell KS et al. | — | 2021 | → |
| Implementation of a Multi-Modal Training Program for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings: Pathways to Comorbidity Care (PCC). | Louie E et al. | — | 2021 | → |
| Longitudinal grey matter changes following first episode mania in bipolar I disorder: A systematic review. | Cahn AJ et al. | — | 2021 | → |
| Principles of Care for Young Adults With Co-Occurring Psychiatric and Substance Use Disorders. | Spencer AE et al. | — | 2021 | → |
| Psychosocial Rehabilitation Interventions in the Treatment of Schizophrenia and Bipolar Disorder. | Yildiz M | — | 2021 | → |
| A Prospective Comparison of Bipolar I and II Subjects With and Without Comorbid Alcohol Dependence From the COGA Dataset. | Preuss UW et al. | — | 2020 | → |
| Clinical Correlates of Alcohol Use Disorder in Depressed Patients with Unipolar and Bipolar Disorder. | Hong M et al. | — | 2019 | → |
| Gender-related differences in patients with bipolar disorder: a nationwide study. | Buoli M et al. | — | 2019 | → |
| Pharmacotherapies for co-occurring substance use and bipolar disorders: A systematic review. | Coles AS et al. | — | 2019 | → |
| Tobacco smoking and other substance use disorders associated with recurrent suicide attempts in bipolar disorder. | Icick R et al. | — | 2019 | → |
| Treatment of substance use disorders with co-occurring severe mental health disorders. | Murthy P et al. | — | 2019 | → |
| Differences in substance use, psychiatric disorders and social factors between Mexican adolescents and young adults. | Tejeda-Romero C et al. | — | 2018 | → |
| Emotional Availability, Neuropsychological Functioning, and Psychopathology: The Context of Parental Substance Use Disorder. | Porreca A et al. | — | 2018 | → |
| Medical Comorbidities in Bipolar Disorder. | Sinha A et al. | — | 2018 | → |
| Substance use comorbidity in bipolar disorder: A qualitative review of treatment strategies and outcomes. | Gold AK et al. | — | 2018 | → |
| The Compelling and Persistent Problem of Bipolar Disorder Disguised as Major Depression Disorder: An Integrative Review [Formula: see text]. | Stiles BM et al. | — | 2018 | → |
| Translating Evidence-Based Practice for Managing Comorbid Substance Use and Mental Illness Using a Multimodal Training Package. | Louie E et al. | — | 2018 | → |